echopointmedical.comCrawled Nov 2, 2026
Advanced Diagnostic Solution: The iKOr microcatheter system enables cardiologists to accurately diagnose complex heart conditions.
The page discusses the clinical challenges of diagnosing ANOCA.
echopointmedical2026-08-24T12:57:26+00:00August 24th, 2026|
Echopoint Medical presented the iKOr system at JPM 2026, highlighting its role in diagnosing microvascular disease.
London, Feb 11, 2025 – Echopoint was honoured to welcome Dr. Tim van De Hoef, a renowned Interventional Cardiologist from the University Medical [...]
The company aims to improve coronary diagnostics by offering a full view of coronary physiology.
Echopoint raises **$2.5 million** in funding to accelerate its **FDA submission** and initiate a **US clinical program**. The company aims to generate **real-world evidence** for its technology through this initiative.
Mar 2026ParkwalkNews article
Echopoint Medical joins the **HeartX Cardiovascular Accelerator**, a program supporting innovators in cardiovascular care. The company advances technologies aimed at improving heart health solutions. HeartX provides resources and networking for early-stage startups in the field.
Oct 2025Echopoint MedicalNews article
Echopoint Medical secures £4.2 million in Series A funding, co-led by Parkwalk Advisors and UCL Technology Fund. Additional investors include AlbionVC. The funding supports the medical technology company’s growth and development.
Feb 2024nordic9.comNews article
UCL researchers deploy the **iKOr device**, a fibre-optic microcatheter, to diagnose heart conditions in patients. The ultra-thin catheter measures blood pressure, flow, and arterial narrowing—key indicators of cardiovascular disease. This marks the first clinical use of the technology in human trials.
Feb 2023UCL NewsNews article